Why Fresenius Medical Care Might Outperform DaVita [Seeking Alpha]
Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)
Last fresenius medical care ag american depositary shares (each representing 1/2 of an ordinary share) earnings: 7/31 04:03 pm
Check Earnings Report
US:NYSE Investor Relations:
freseniusmedicalcare.com/en/investors/investors-overview
Company Research
Source: Seeking Alpha
Summary While Fresenius Medical Care had usually traded at a premium to its smaller peer DaVita, it has greatly underperformed in recent months. A review of both companies' latest figures gives little reason to be excited for either of them. However, there are some arguments in favor of a slight future outperformance of Fresenius. Fresenius' rare underperformance of DaVita Four months ago, I covered on this site FMS In fact, the stock has roughly performed in-line with the S&P 500 since then, returning 13% vs. 12% of the index. However, in the meantime, despite no really exciting news and much larger exposure to the difficult U.S. market, Fresenius' competitor DaVita ( DVA Q3/19 review So, after many years of lagging Fresenius, DaVita is currently experiencing some sort of revenge rally, while Fresenius is hovering near multi-year lows. Since I suspect the decoupling of the two companies' stock market performances might not last long, the question is whether there might soon be a Fres
Show less
Read more
Impact Snapshot
Event Time:
FMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FMS alerts
High impacting Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) news events
Weekly update
A roundup of the hottest topics
FMS
News
- Global Hemodialysis and Peritoneal Dialysis Research Report 2024-2029: Increasing Growth Opportunities in Emerging Economies, Rising Number of Dialysis Centers, Growing Preference for Home Care [Yahoo! Finance]Yahoo! Finance
- Fresenius Medical Care AG (NYSE: FMS) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last five years, but the stock soars 14% this past week [Yahoo! Finance]Yahoo! Finance
- Fresenius Medical Care AG (NYSE: FMS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S. [Yahoo! Finance]Yahoo! Finance
FMS
Earnings
- 8/3/23 - In-Line
FMS
Sec Filings
- 5/3/24 - Form 6-K
- 3/28/24 - Form 6-K
- 3/13/24 - Form 6-K
- FMS's page on the SEC website